AiCuris Anti-infective Cures AG is dedicated to developing precise therapies for immunocompromised patients facing infections. Their flagship product, PREVYMIS, treats CMV in transplant recipients, while Pritelivir aims to address recurrent and resistant HSV infections. With a focus on anti-infectives and virology, AiCuris leverages pre-clinical and clinical development expertise to provide critical therapeutic solutions for vulnerable patient populations.
The Medical Science Liaison (MSL) is a field-based scientific and clinical expert required to reside within the assigned geographic territory. The MSL will establish and maintain relationships with healthcare professionals, key opinion leaders, academic institutions, and professional societies, providing fair, balanced, and compliant scientific exchange on topics including disease state, current therapeutic landscape, as well as AiCuris clinical stage antiviral agents and products in development.
AiCuris Anti-infective Cures AG is dedicated to developing precise therapies for immunocompromised patients facing infections. Their flagship product, PREVYMIS, treats CMV in transplant recipients, while Pritelivir aims to address recurrent and resistant HSV infections. With a focus on anti-infectives and virology, AiCuris leverages pre-clinical and clinical development expertise to provide critical therapeutic solutions for vulnerable patient populations.
Karius